Research Publications by Neil H. Riordan, PA, PhD
Outstanding survival and regeneration process by the use of intelligent acellular dermal matrices and mesenchymal stem cells in a burn pig model.
Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis
High-Dose Intravenous Vitamin C Treatment of a Child with Neurofibromatosis Type 1 and Optic Pathway Glioma: A Case Report.
Effect of Infla-Kine supplementation on the gene expression of inflammatory markers in peripheral mononuclear cells and on C-reactive protein in blood.
Effect of Infla-Kine supplementation on the gene expression of inflammatory markers in peripheral mononuclear cells and on C-reactive protein in blood.
Case report of non-healing surgical wound treated with dehydrated human amniotic membrane.
Scalable efficient expansion of mesenchymal stem cells in xeno free media using commercially available reagents.
A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods.
Minimally Invasive Autologous Bone Marrow Concentrate Stem Cells in the Treatment of the Chronically Injured Achilles Tendon: A Case Report
Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy.
Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients.
Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients.
Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety.
Schedule Dependence in Cancer Therapy: Intravenous Vitamin C and the Systemic Saturation Hypothesis.
J Transl Med. 2011 Dec 20;9:218. doi: 10.1186/1479-5876-9-218. Ichim T, [...]
IFN-conditioned dendritic cells for the therapy of melanoma: what is missing?
Targeted gene silencing of TLR4 using liposomal nanoparticles for preventing liver ischemia reperfusion injury.
Could metabolic syndrome, lipodystrophy, and aging be mesenchymal stem cell exhaustion syndromes?
Increased Level of Circulating Endothelial Microparticles and Cardiovascular Risk Factors.
Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?
Cutaneous sarcoidosis and malignancy: An association between sarcoidosis with skin manifestations and systemic neoplasia.
Prevention of hyperglycemia-induced myocardial apoptosis by gene silencing of Toll-like receptor-4.
Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report.
Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions.
Autologous stromal vascular fraction cells: a tool for facilitating tolerance in rheumatic disease.
Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy.
Vitamin D concentrations, endothelial progenitor cells, and cardiovascular risk factors.
Circulating endothelial progenitor cells and erectile dysfunction: possibility of nutritional intervention?
Nutraceutical augmentation of circulating endothelial progenitor cells and hematopoietic stem cells in human subjects.
The lysosomotropic agent, hydroxychloroquine, delivered in a biodegradable nanoparticle system, overcomes drug resistance of B-chronic lymphocytic leukemia cells in vitro.
The lysosomotropic agent, hydroxychloroquine, delivered in a biodegradable nanoparticle system, overcomes drug resistance of B-chronic lymphocytic leukemia cells in vitro.
The next generation of burns treatment: intelligent films and matrix, controlled enzymatic debridement, and adult stem cells.
Ascorbate inhibition of angiogenesis in aortic rings ex vivo and subcutaneous Matrigel plugs in vivo.
Circulating endothelial progenitor cells: a new approach to anti-aging medicine?
Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis.
Feasibility investigation of allogeneic endometrial regenerative cells.
Inhibition of intracranial glioma growth by endometrial regenerative cells.
Granulocyte activity in patients with cancer and healthy subjects.
Allogeneic endometrial regenerative cells: an “Off the shelf solution” for critical limb ischemia?
Exosomes as a tumor immune escape mechanism: possible therapeutic implications.
Immune effects of mesenchymal stem cells: implications for Charcot-Marie-Tooth disease.
Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathy.
Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate.
Vitamin C pharmacokinetics after continuous infusion in a patient with prostate cancer.
Cord blood in regenerative medicine: do we need immune suppression?
The paradoxical role of lipid peroxidation on carcinogenesis and tumor growth: a commentary.
Induction of antitumor immunity through xenoplacental immunization.
Tumor growth parameters of in-vivo human breast carcinoma: a proposed mathematical model for tumor growth kinetics.
A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients.
Orthomolecular oncology review: ascorbic acid and cancer 25 years later.
L-ascorbic acid represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60.
Intravenous vitamin C as a chemotherapy agent: a report on clinical cases.
Cell membrane fatty acid composition differs between normal and malignant cell lines.
Prevention of venous thrombosis in long-haul flights with Flite Tabs: the LONFLITE-FLITE randomized, controlled trial.
Intravenous ascorbic acid: protocol for its application and use.
Effects of a high molecular mass Convolvulus arvensis extract on tumor growth and angiogenesis.
Orthomolecular oncology: a mechanistic view of intravenous ascorbate’s chemotherapeutic activity.
Inhibition of human breast carcinoma cell proliferation by ascorbate and copper.
Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours.
Integrative medicine: a paradigm shift in medical education and practice.
Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent.
Improved microplate fluorometer counting of viable tumor and normal cells.